PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate- A Pharmacovigilance Analysis of the Adverse Event Reporting System

Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1724
https://www.valueinhealthjournal.com/article/S1098-3015(12)03437-7/fulltext
Title : PSY1 Cardiovascular and Congenital Safety Evaluation of Antiobesity Agents, Including Topiramate- A Pharmacovigilance Analysis of the Adverse Event Reporting System
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)03437-7&doi=10.1016/j.jval.2012.08.1724
First page : A508
Section Title : Systemic Disorders/Conditions
Open access? : No
Section Order : 1217
Categories :
Tags :
Regions :
ViH Article Tags :